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The development and persistence of multidrug-
resistant bacteria pose increasing challenges to
public health (Institute of Medicine 1998).
Although the use of antibiotics in human
medicine has influenced the emergence of
antibiotic-resistant bacteria, the use of anti-
biotics in animal agriculture has markedly
contributed to this critical problem as well
(Cohen and Tauxe 1986; Gorbach 2001;
Institute of Medicine 1998; National
Research Council 1999; van den Boogard and
Stobberingh 1999). In animal agriculture,
antibiotics are administered for therapeutic
purposes to treat infections, prophylactic pur-
poses in advance of observed symptoms, and
nontherapeutic purposes to promote growth
and improve feed efﬁciency (Wegener 2003).
In general, antibiotics are administered at
higher concentrations for therapeutic and pro-
phylactic use and lower concentrations for
nontherapeutic use (Wegener 2003). It has
been estimated that the nontherapeutic use of
antimicrobials in livestock production com-
prises 60–80% of total antimicrobial produc-
tion in the United States (Mellon et al. 2001).
The swine industry alone uses an estimated
10.3 million pounds of antibiotics annually for
nontherapeutic purposes. Among the anti-
biotics used are ampicillin, bacitracin, erythro-
mycin, lincomycin, virginiamycin, and
tetracycline (Food and Drug Administration
2004), some of which are important in human
clinical medicine. The use of antibiotics for
nontherapeutic purposes such as growth pro-
motion has been shown to select for resistance
to high concentrations of antibiotics in both
pathogenic and commensal bacteria in swine
(Aarestrup et al. 2000a, 2000b; Bager et al.
1997; Jensen et al. 2002; Wegener et al.
1999). For this reason, attention has been
given to retail pork products as a source of
human exposure to antibiotic-resistant bacteria
(Donabedian et al. 2003; Gambarotto et al.
2001; Hayes et al. 2003; Sorensen et al. 2001;
White et al. 2001). Yet the ingestion of pork
products is not the only pathway of exposure
for the transfer of resistant organisms from
swine to humans. Environmental pathways of
exposure may be equally important.
Along with the pork products, more than
110 million tons of swine waste—containing
antibiotic-resistant bacteria—is produced at
swine concentrated animal feeding operations
(CAFOs) in the United States each year
(Environmental Defense 1997). The practice
of storing this waste in pits and open-air
lagoons and subsequently applying the waste
to land can lead to the contamination of soils
and nearby surface and groundwaters. Several
studies have reported the appearance of anti-
biotic residues and antibiotic-resistant bacte-
ria in surface and groundwaters proximal to
swine CAFOs (Campagnolo et al. 2002;
Chee-Sanford et al. 2001). Campagnolo et al.
(2002) suggested that swine waste may be a
source of antimicrobial drugs in surface and
groundwaters near swine facilities, and Chee-
Sanford et al. (2001) found that groundwater
can be affected by swine waste and serve as a
potential source of exposure to antibiotic-
resistance genes.
However, few studies have examined the air
within swine CAFOs as an additional source of
environmental exposure to antibiotic-resistant
bacterial pathogens. It has been well docu-
mented that the air within swine CAFOs is
highly contaminated with bacteria, yeasts, and
molds. Mean total bacterial concentrations can
range from 104 to 107 colony forming units
(CFU)/m3 (Clark et al. 1983; Cormier et al.
1990; Crook et al. 1991; Predicala et al. 2002).
Specific bacteria detected in the air of swine
CAFOs have included the following potential
human pathogens: Enterococcus, Staphylococcus,
Pseudomonas, Bacillus, Listeria, and Escherichia
coli (Cormier et al. 1990; Crook et al. 1991;
Predicala et al. 2002). Yet, to date, these air-
borne pathogens have not been assessed for
resistance to antibiotics that are commonly
used in both swine production and clinical
medicine. Hamscher et al. (2003) assessed the
presence of antibiotics in dust samples collected
at a swine production facility over two decades.
Several different antibiotics, including tetra-
cycline, tylosin (an analog to erythromycin),
and chloramphenicol, could be detected in
90% of the dust samples tested (Hamscher
et al. 2003). In abstract form within confer-
ence proceedings, Zahn et al. (2001) reported
on the presence of tylosin and tylosin-resistant
bacteria in the air released from three
mechanically ventilated swine CAFOs. Their
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The use of nontherapeutic levels of antibiotics in swine production can select for antibiotic resis-
tance in commensal and pathogenic bacteria in swine. As a result, retail pork products, as well as
surface and groundwaters contaminated with swine waste, have been shown to be sources of human
exposure to antibiotic-resistant bacteria. However, it is unclear whether the air within swine opera-
tions also serves as a source of exposure to antibiotic-resistant bacterial pathogens. To investigate
this issue, we sampled the air within a concentrated swine feeding operation with an all-glass
impinger. Samples were analyzed using a method for the isolation of Enterococcus. A total of
137 presumptive Enterococcus isolates were identiﬁed to species level using standard biochemical
tests and analyzed for resistance to erythromycin, clindamycin, virginiamycin, tetracycline, and
vancomycin using the agar dilution method. Thirty-four percent of the isolates were conﬁrmed as
Enterococcus, 32% were identiﬁed as coagulase-negative staphylococci, and 33% were identiﬁed as
viridans group streptococci. Regardless of bacterial species, 98% of the isolates expressed high-level
resistance to at least two antibiotics commonly used in swine production. None of the isolates
were resistant to vancomycin, an antibiotic that has never been approved for use in livestock in the
United States. In conclusion, high-level multidrug-resistant Enterococcus, coagulase-negative
staphylococci, and viridans group streptococci were detected in the air of a concentrated swine
feeding operation. These ﬁndings suggest that the inhalation of air from these facilities may serve
as an exposure pathway for the transfer of multidrug-resistant bacterial pathogens from swine to
humans. Key words: air sampling, airborne bacteria, antibiotic resistance, CAFO, concentrated
swine feeding operation, multidrug-resistant bacteria. Environ Health Perspect 113:137–142
(2005). doi:10.1289/ehp.7473 available via http://dx.doi.org/ [Online 22 November 2004]
Research Articlestudy indicated that tylosin-resistant bacteria,
primarily Corynebacterium, accounted for 80%
of total culturable bacteria detected. These
results provided the ﬁrst evidence of airborne
antibiotic-resistant bacteria in swine CAFOs.
The goal of this study was to test air sam-
ples collected within a swine CAFO for the
presence of antibiotic-resistant enterococci,
gram-positive, catalase-negative cocci that are
not only members of the normal intestinal ﬂora
of humans and animals but also capable of
causing a variety of human and animal infec-
tions [National Nosocomial Infections
Surveillance (NNIS) 2001]. Resistance to
erythromycin, clindamycin, tetracycline, and
virginiamycin [an analog to quinupristin/
dalfopristin, which is used to treat vancomycin-
resistant Enterococcus faecium infections in
humans (Johnson and Livermore 1999)] was
investigated. These drugs (or their analogs)
have been approved for use in swine produc-
tion for growth promotion, feed efficiency,
and therapeutic purposes. Resistance to vanco-
mycin also was tested. Vancomycin, an analog
to avoparcin, which has been used extensively
in animal agriculture in Europe, has never
been approved for use in livestock in the
United States.
Materials and Methods
Study site. The study site is a swine ﬁnishing
CAFO located in the Mid-Atlantic United
States. The CAFO consists of two tunnel-
ventilated swine houses built atop 12-ft deep
concrete pits where swine waste is stored
before periodic siphoning into a transport
truck for off-farm disposal by land applica-
tion. Each house has the capacity to hold
2,500 hogs; however, during the sampling
period approximately 1,500 hogs were being
housed in each building. Air sampling at the
swine facility was conducted on 9 December
2003 and 5 January 2004.
Collection of air samples. Air samples were
collected at a calibrated ﬂow rate of 12.5 L/min
using all-glass impingers (AGI-30; Ace Glass,
Vineland, NJ) designed to collect respirable
particles, including bioaerosols, with an aero-
dynamic diameter < 5 µm. Impingers were
autoclaved and ﬁlled with 20 mL phosphate-
buffered saline (PBS) before sampling. On
the first sampling day, sampling was con-
ducted over a 30-min period. On the second
sampling day, sampling was conducted for
60 min in order to increase yield. For the
longer sampling period, the impinger solution
was replenished with distilled deionized H2O
to maintain the sampler collection efﬁciency
(Lin et al. 1997) and avoid increasing liquid
salinity. All sampling equipment was placed
on top of a table (1.5 m from the ground)
within an empty swine stall located within the
facility approximately 30 m from the south
wall of the swine facility where air exits
through ventilation fans. At the time of sam-
pling, four of eight 32-inch ventilation fans
were in operation to maintain a farm-operator–
designated target temperature of 21°C within
the facility. Temperature and relative humid-
ity were monitored throughout the sampling
periods and were 22°C ± 1°C and 76 ± 4%
respectively. Impingers were stored and trans-
ported back to the laboratory at 4°C.
Bacterial isolation and speciation.
Approximately 3 hr after the last air sample
was collected, impinger liquid samples were
analyzed in the laboratory. Because no stan-
dard method exists regarding the isolation of
Enterococcus from air, the standard methods
used for the isolation of Enterococcus from
recreational water were modiﬁed to accommo-
date the air samples [U.S. Environmental
Protection Agency (EPA) 2000]. All broths
and agars were obtained from Becton
Dickinson (Sparks, MD). Three 10-fold dilu-
tions (using PBS as the diluent) of the
impinger samples were plated (100 µL/plate)
in duplicate on mE agar. Negative control
plates were made by plating 100 µL of both
the replenishing ﬂuid that was transported to
the site and the dilution liquid. All plates were
incubated for 48 hr at 41.5°C under aerobic
conditions. All resulting colonies were
counted, and counts from dilution plates
containing 30–300 CFU were used in back-
calculations to determine the concentration of
isolated bacteria per cubic meter of air within
the swine CAFO. Colonies from sample dilu-
tion plates that ranged from pink to red in
color (indicative of Enterococcus colonies) were
streaked onto Enterococcosel agar and incu-
bated for 24 hr at 41.5°C under aerobic con-
ditions. CFUs characteristic of Enterococcus
that formed a black precipitate on the
Enterococcosel agar plates were considered
presumptive Enterococcus (U.S. EPA 2000).
Presumptive Enterococcus isolates were
archived in a 20% glycerol, tryptic soy broth
solution at –80°C for subsequent speciation
and antimicrobial susceptibility testing.
All presumptive Enterococcus isolates, as
well as the quality control strains E. faecium
19434 and Enterococcus faecalis 29212
(American Type Culture Collection, Manassas,
VA), were streaked from –80°C archived
stocks onto both tryptic soy agar and tryptic
soy agar No. 2 with 5% defibrinated sheep
blood (Quad Five, Ryegate, MT) and incu-
bated for 24 hr at 37°C. All of the media for-
mulations and test interpretations used have
been described previously (Murray et al. 2003).
Gram stains were prepared on all isolates to
verify the presence of gram-positive cocci. Each
isolate was tested for the production of catalase
in the presence of 3% hydrogen peroxide.
Catalase-positive isolates were identified as
Staphylococcus species (except for one isolate,
which was further tested for oxidase activity
and identified as Micrococcus luteus). Each
Staphylococcus isolate was inoculated onto
0.5 mL rabbit plasma (Becton Dickinson) to
test for the production of coagulase. Catalase-
negative isolates were differentiated further by
pyrrolidonyl-arylamidase activity using Remel’s
PYR kit (Remel, Lenexa, KS). The following
biochemical tests were performed on the iso-
lates displaying pyrrolidonyl-arylamidase activ-
ity: mannitol, arabinose, sorbitol, raffinose,
lactose, and sucrose carbohydrate fermentation
tests; arginine deamination; acidification of
methyl-α-D-glucopyranoside; pyruvate utiliza-
tion; and isolate pigmentation.
Antimicrobial susceptibility testing.
Antimicrobial susceptibility testing was con-
ducted using the minimal inhibitory concen-
tration (MIC) agar dilution method [National
Committee for Clinical Laboratory Standards
(NCCLS) 2002]. E. faecalis 29212 was used
as the quality control reference strain.
Susceptibility to erythromycin, clindamycin,
virginiamycin (streptogramin A and B combi-
nation), tetracycline, and vancomycin was
tested. Erythromycin, clindamycin, tetra-
cycline, and vancomycin were obtained from
Sigma (St. Louis, MO). Virginiamycin was
obtained from Research Products International
Corp. (Mt. Prospect, IL). Concentrations of
antibiotics tested ranged from 0.5 µg/mL to
256 µg/mL for erythromycin and tetracycline,
0.03 µg/mL to 128 µg/mL for clindamycin,
0.03 µg/mL to 32 µg/mL for virginiamycin,
and 0.03 µg/mL to 64 µg/mL for vancomycin.
In preparation for the agar dilution tests,
the air sample isolates, as well as the MIC ref-
erence strain E. faecalis 29212, were streaked
from –80°C archived stocks onto tryptic soy
agar No. 2 with 5% deﬁbrinated sheep blood
(QuadFive, Ryegate, MT) and incubated for
24 hr at 37°C. After 24 hr, each isolate was
suspended in 3 mL Mueller-Hinton broth
with a sterile cotton swab and adjusted to a
0.5 McFarland standard using a Vitek colori-
meter (Hach, Loveland, CO). Two hundred
microliters of each suspension was transferred
to a well within a Cathra replicator plate
(Oxoid Inc., Ogdensburg, NY) and replicated
with 1-mm pins in accordance with NCCLS
guidelines onto Mueller-Hinton agar plates
that were previously prepared with the appro-
priate concentrations of antibiotics (NCCLS
2002). Plates were incubated for 24 hr at
37°C under aerobic conditions. After 24 hr,
the plates were read manually and MICs were
determined. Specifically, the MIC was
recorded as the minimum antibiotic concen-
tration that completely inhibited bacterial
growth. According to the MIC, isolates were
categorized as susceptible, intermediate, or
resistant to each antibiotic using the following
MIC breakpoints established by the NCCLS
for Enterococcus: erythromycin, susceptible
≤ 0.5 µg/mL, intermediate 1–4 µg/mL, and
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≤ 0.5 µg/mL, intermediate 1–2 µg/mL, and
resistant ≥ 4 µg/mL; virginiamycin, suscepti-
ble ≤ 1 µg/mL, intermediate 2 µg/mL, and
resistant ≥ 4 µg/mL; tetracycline, susceptible
≤ 4 µg/mL, intermediate 8 µg/mL, and resis-
tant ≥ 16 µg/mL; and vancomycin, suscepti-
ble ≤ 4 µg/mL, intermediate 8–16 µg/mL,
and resistant ≥ 32 µg/mL (NCCLS 2002).
Results
Bacterial concentrations in air and bacterial
identiﬁcation. The mean concentration of pre-
sumptive Enterococcus present in the air of the
swine CAFO on both 9 December 2003 and
5 January 2004 was 4 × 104 CFU/m3. After
bacterial speciation was completed on 137 pre-
sumptive Enterococcus isolates, only 47 out of
137 isolates (34%) were confirmed to be
Enterococcus (Table 1). Forty-four isolates
(32%) were identiﬁed as staphylococci, 45 iso-
lates (33%) were viridans group streptococci,
and 1 isolate was identified as Micrococcus
luteus (Table 1).
Antibiotic resistance. Ninety-eight percent
(121 of 124) of the bacterial isolates that grew
successfully during the antimicrobial suscepti-
bility tests were resistant to high levels of at
least two antibiotics commonly used in swine
production (erythromycin, clindamycin,
virginiamycin, or tetracycline), and 93% of
the isolates (115 of 124) were resistant to
three antibiotics commonly used in swine
production. Individually, 98% of the isolates
were resistant to erythromycin, 94% were
resistant to clindamycin, 90% were resistant
to tetracycline, and 37% were resistant to vir-
giniamycin. None of the isolates displayed
resistance to vancomycin. Because none of the
E. avium, E. pseudoavium, or E. rafﬁnosus iso-
lates (all belonging to the Enterococcus physio-
logic group I) grew successfully on the control
or antibiotic-amended MIC plates after being
suspended as 0.5 McFarland standard solu-
tions, MIC data for these isolates were not
determined. MIC distributions among all
other isolates were similar for erythromycin,
clindamycin, tetracycline, and vancomycin,
regardless of bacterial genus or species
(Tables 2 and 3). For instance, across all
organisms, most isolates (96%) had MICs
> 256 µg/mL for erythromycin (Tables 2
and 3). In contrast, resistance to virgini-
amycin was more prevalent among coagulase-
negative staphylococci versus Enterococcus or
Streptococcus isolates (Tables 2 and 3).
Phenotypes of antibiotic resistance among the
bacterial isolates appear in Table 4.
Discussion
In this study, multidrug-resistant Enterococcus,
coagulase-negative staphylcocci, and viridans
group streptococci were isolated from the air
of a swine CAFO. Ninety-eight percent of
the isolates were resistant to at least two of
the following antibiotics: erythromycin,
clindamycin, virginiamycin, and tetracy-
cline, all of which are approved for use in
swine production for growth promotion. In
contrast, none of the isolates were resistant
to vancomycin, which has never been
approved for use in swine production in the
United States. These results support the
findings of previous reports that non-
therapeutic use of antibiotics results in the
presence of antibiotic-resistant bacteria in
swine (Aarestrup et al. 2000a, 2000b; Bager
et al. 1997; Jensen et al. 2002; Wegener et al.
1999). In addition, these results provide evi-
dence that in the absence of nontherapeutic
antibiotic use—vancomycin in this case—no
resistance is detected among bacteria present
in the swine environment.
Furthermore, these ﬁndings suggest that,
in addition to the ingestion of retail pork
products (Gambarotto et al. 2001; Hayes et al.
2003; Sorensen et al. 2001; White et al. 2001)
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Table 1. Airborne bacteria isolated from a swine
CAFO using methods for the isolation of
Enterococcus species.
Bacteria No. of isolates (%)
Enterococcus 47 (34)
E. avium 5 (4)
E. dispar 4 (3)
E. durans 2 (1)
E. faecalis 6 (4)
E. faecium 1 (< 1)
E. hirae 14 (10)
E. mundtii 1 (< 1)
E. pseudoavium 2 (1)
E. rafﬁnosus 1 (< 1)
Other 11 (8)
Staphylococcus 44 (32)
S. aureus 1 (< 1)
Coagulase-negative staphylococci 43 (31)
Streptococcus
Viridans group streptococci 45 (33)
Micrococcus luteus 1 (< 1)
Total 137 (100)
Table 2. MIC distributions for ﬁve antibiotics observed in airborne Enterococcus collected from a swine CAFO.
No. of bacterial isolates with the following MICs (µg/mL)
Bacteria, antibiotic ≤ 0 . 5 12481 63 26 4 1 2 8 2 5 6 >  2 5 6 % S % I % R
Enterococcus (n = 38)
Erythromycin 1 37 0 3 97
Clindamycin 1 1 1 1 3 8 23a 30 9 7
Virginiamycin 19 5 5 9 63 13 24
Tetracycline 1 2 7 6 17 5 3 5 92
Vancomycin 38 100 0 0
E. dispar (n = 4)
Erythromycin 4 0 0 100
Clindamycin 1 1 2a 0 0 100
Virginiamycin 4 100 0 0
Tetracycline 3 1 0 0 100
Vancomycin 4 100 0 0
E. durans (n = 2)
Erythromycin 2 0 0 100
Clindamycin 1 1a 0 0 100
Virginiamycin 1 1 0 50 50
Tetracycline 1 1 50 50 0
Vancomycin 2 100 0 0
E. faecalis (n = 6)
Erythromycin 1 5 17 0 83
Clindamycin 1 1 2 2a 17 0 83
Virginiamycin 2 3 1 83 0 17
Tetracycline 2 1 2 1 0 0 100
Vancomycin 6 100 0 0
E. faecium (n = 1)
Erythromycin 1 0 0 100
Clindamycin 1 0 0 100
Virginiamycin 1 0 0 100
Tetracycline 1 0 0 100
Vancomycin 1 100 0 0
E. hirae (n = 14)
Erythromycin 14 0 0 100
Clindamycin 2 12a 0 0 100
Virginiamycin 8 2 4 57 14 29
Tetracycline 1 2 1 8 2 0 7 93
Vancomycin 14 100 0 0
Other (n = 11)
Erythromycin 11 0 0 100
Clindamycin 1 1 2 1 6a 0 0 100
Virginiamycin 5 2 2 2 64 18 18
Tetracycline 2 4 4 1 0 0 100
Vancomycin 11 100 0 0
Abbreviations: %I, percent intermediate; %R, percent resistant; %S, percent susceptible.
aMIC is > 128 µg/mL.and surface and groundwaters in the vicinity
of swine CAFOs (Campagnolo et al. 2002;
Chee-Sanford et al. 2001), the inhalation of
air within swine operations may serve as
another exposure pathway for the transfer of
multidrug-resistant bacteria from swine to
humans. These data are especially relevant to
the health of swine CAFO workers, their
direct contacts in the community, and possi-
bly nearby neighbors of swine CAFOs.
The types of bacteria detected within the
air of the swine facility investigated in this
study are associated with a variety of human
infections. Enterococcus, particularly some of
the species isolated in this study including
E. faecalis and E. faecium, has emerged as one
of the leading causes of nosocomial bac-
teremias, urinary tract infections, and wound
infections in the United States (NNIS 2001).
Similarly, coagulase-negative staphylococci
are the third most common causes of noso-
comial infections and the most common
causes of nosocomial bacteremias. The pres-
ence of multidrug-resistant Enterococcus and
coagulase-negative staphylococci in patients
significantly limits the treatment options
available for these life-threatening infections.
Although viridans group streptococci are part of
the normal ﬂora of the human respiratory tract,
they also have been implicated as the cause of
infective endocarditis and life-threatening sep-
ticemias in neutropenic patients. In addition,
viridans group streptococci have been impli-
cated as reservoirs of erythromycin-resistance
genes, possibly capable of transferring resis-
tance determinants to more pathogenic species
including Streptococcus pneumoniae and
Streptococcus pyogenes (Bryskier 2002).
Of particular concern to the health of
individuals with direct or indirect contact
with swine environments is the finding of 
virginiamycin-resistant gram-positive bacteria
in the air of the swine CAFO. Virginiamycin,
a streptogramin A and B combination, which
has been used extensively as a growth pro-
moter in swine, is an analog to quinupristin-
dalfopristin, an injectable streptogramin A
and B combination that is often the drug of
last resort for multidrug-resistant gram-positive
infections characterized by methicillin-resistant
Staphylococcus aureus and glycopeptide-resistant
E. faecium and coagulase-negative staphylo-
cocci (Johnson and Livermore 1999). Bacteria
expressing resistance to virginiamycin are cross-
resistant to quinupristin-dalfopristin, and a
previous study has suggested that the transfer
of streptogramin-resistant Enterococcus can
occur between animals and humans in the live-
stock environment (Jensen et al. 1998). Thus,
the inhalation of virginiamycin-resistant gram-
positive bacteria in the swine environment could
contribute to the appearance of quinupristin-
dalfopristin–resistant gram-positive infections
in humans, leaving few or no treatment options
for the affected individual.
The finding of airborne clindamycin-
resistant gram-positive bacteria in this study
also is a potential concern to public health.
Clindamycin is indicated for the treatment of
human staphylococcal and streptococcal pneu-
monia (among other aerobic and anaerobic
infections). Speciﬁcally, clindamycin has been
used for the treatment of community-acquired
methicillin-resistant S. aureus (Marcinak and
Frank 2003). Clindamycin also has been shown
to be signiﬁcantly more potent than penicillin
in inhibiting both invasive and noninvasive
group A streptococci such as S. pyogenes
(Mascini et al. 2001). The ﬁndings of airborne
clindamycin-resistant coagulase-negative
staphylococci and viridans group streptococci
in the swine environment raise the question as
to whether these organisms could serve as
reservoirs of clindamycin-resistant genes [as
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Table 3. MIC distributions for five antibiotics observed in airborne Staphylococcus and Streptococcus
collected from a swine CAFO.
Number of bacterial isolates with the following MICs (µg/mL)
Bacteria, antibiotic ≤ 0 . 5 12481 63 26 4 1 2 8 2 5 6 >  2 5 6 % S % I % R
Staphylococcus (n = 43)a
S. aureus (n = 1)
Erythromycin 1 0 0 100
Clindamycin 1b 0 0 100
Virginiamycin 1 0 100 0
Tetracycline 1 0 0 100
Vancomycin 1 100 0 0
Coagulase-negative
staphylococci (n = 42)
Erythromycin 42 0 0 100
Clindamycin 1 2 39b 02 9 8
Virginiamycin 4 2 2 21 13 14 5 81
Tetracycline 2 1 1 5 12 13 7 1 7 0 93
Vancomycin 7 3 30 2 100 0 0
Streptococcus (n = 43)c
Viridans group streptococci
Erythromycin 1 1 1 40 0 0 100
Clindamycin 2 2 2 9 28 5 0 95
Virginiamycin 29 7 4 3 84 9 7
Tetracycline 1 8 17 10 7 2 0 98
Vancomycin 43 100 0 0
Abbreviations: %I, percent intermediate; %R, percent resistant; %S, percent susceptible.
aAnalyzed using the breakpoints for Enterococcus. bMIC is > 128 µg/mL. cAnalyzed using the following breakpoints: ery-
thromycin, susceptible ≤ 0.25 µg/mL, intermediate 0.5 µg/mL, and resistant ≥ 1.0 µg/mL; clindamycin, susceptible ≤ 0.5 µg/mL,
intermediate 1–2 µg/mL, and resistant ≥ 4 µg/mL; virginiamycin, susceptible ≤ 1 µg/mL, intermediate 2 µg/mL, and resistant
≥ 4 µg/mL; tetracycline, susceptible ≤ 2 µg/mL, intermediate 4 µg/mL, and resistant ≥ 8 µg/mL; vancomycin, susceptible
≤ 1 µg/mL, intermediate and resistant not available (NCCLS 2002). 
Table 4. Phenotypes of antibiotic resistance among airborne bacteria collected from a swine CAFO.
Bacteria Antibiotic resistance pattern No. of isolates (%)
Enterococcus
E. dispar (n = 4) Ery, Clin, Tet 4 (100)
E. durans (n = 2) Ery, Clin 1 (50)
Ery, Clin, Virg 1 (50)
E. faecalis (n = 6) Tet 1 (17)
Ery, Clin, Tet 4 (66)
Ery, Clin, Tet, Virg 1 (17)
E. faecium (n = 1) Ery, Clin, Tet, Virg 1 (100)
E. hirae (n = 14) Ery, Clin 1 (7)
Ery, Clin, Tet 9 (64)
Ery, Clin, Tet, Virg 4 (29)
Other Enterococcus (n = 11) Ery, Clin, Tet 9 (82)
Ery, Clin, Tet, Virg 2 (18)
Staphylococcus aureus (n = 1) Ery, Clin, Tet 1 (100)
Coagulase-negative staphylococci (n = 42) Ery, Tet 1 (2)
Ery, Clin, Tet 8 (19)
Ery, Clin, Virg 6 (14)
Ery, Virg, Tet 1 (2)
Ery, Clin, Tet, Virg 26 (62)
Viridans group streptococci (n = 43) Tet 2 (5)
Ery, Clin 1 (2)
Ery, Tet 2 (5)
Ery, Clin, Tet 35 (81)
Ery, Clin, Tet, Virg 3 (7)
Abbreviations: Clin, clindamycin; Ery, erythromycin; Tet, tetracycline; Virg, virginiamycin.well as reservoirs of erythromycin-resistant
genes (Bryskier 2002)], passing on clindamycin
resistance determinants to more pathogenic
species as described above.
Furthermore, exposure to virginiamycin-,
erythromycin-, clindamycin-, and tetracycline-
resistant Enterococcus, coagulase-negative
staphylococci, and viridans group streptococci
through the inhalation of contaminated air
could lead to the colonization of these multi-
drug-resistant organisms in both the nasal pas-
sages (Aubry-Damon 2004) and the lungs of
swine CAFO workers, potentially making the
workers themselves reservoirs of antibiotic-
resistant organisms. Coexposures to other
aerosols and gases in the swine environment
such as organic dusts, molds, and ammonia
have been shown to induce symptoms associ-
ated with chronic bronchitis, including a per-
sistent cough characterized by expectoration
(Mackiewicz 1998). The presence of this type
of cough can increase the potential for sec-
ondary spread of antibiotic-resistant organisms
into the community, where additional indi-
viduals could serve as reservoirs of multidrug-
resistant bacteria.
Moreover, the tunnel-ventilated design of
swine CAFOs, which moves air outside of the
facilities at a high flow rate, could create a
situation where neighbors living downwind of
the ventilation fans also could be directly
exposed to airborne multidrug-resistant bacte-
ria. An epidemiologic study by Wing and
Wolf (2000) indicated that people who live in
the vicinity of swine CAFOs experience ele-
vated rates of headaches, runny noses, sore
throats, excessive coughing, and diarrhea
compared with people living in communities
that are not situated near livestock operations.
The findings of airborne multidrug-resistant
bacteria in a swine CAFO in our study raise
the question as to whether airborne bacteria
also could travel beyond the confines of the
swine CAFO on ventilation fan air currents,
directly contacting nearby neighbors and
potentially contributing to health effects such
as those observed in the Wing and Wolf
study. Because populations living in areas
where swine CAFOs are built already may
experience higher rates of certain diseases
because of lack of access to appropriate health
care (Weber et al. 1989), investigating air-
borne exposures to multidrug-resistant bacte-
ria among these at-risk populations is an
important area for future research.
In addition to potential airborne expo-
sures occurring among individuals living near
swine CAFOs, the results of this study could
have broader public health implications.
Specifically, one may question whether air-
borne exposures to multidrug-resistant bacteria
could be occurring and contributing to health
problems around other environmental sources
of animal or human waste, including land
application areas for animal waste and human
sludge, and human wastewater treatment
facilities. Endotoxins, exotoxins, and other
chemical components in dusts associated with
animal waste and human sludge have been
linked to hypersensitivity reactions among
individuals living near land application areas
(Lewis and Gattie 2002). These reactions have
been shown to result in increased susceptibility
to serious respiratory infections, including
those caused by S. aureus (Lewis and Gattie
2002). Thus, the presence of high concentra-
tions of multidrug-resistant staphylococci and
other bacterial pathogens amidst endotoxin-
containing dust from animal and human waste
could pose unique health concerns to people
living near land application areas.
Conclusions
In summation, the ﬁndings of this study sug-
gest that the inhalation of air from swine
CAFOs may serve as an additional environ-
mental exposure pathway for the transfer of
multidrug-resistant bacterial pathogens from
swine to humans. Given the growing interest
in reservoirs of antibiotic resistance genes asso-
ciated with large-scale livestock operations
(Nandi et al. 2004), our ﬁndings in this inves-
tigation emphasize the importance of studying
multiple genera of bacteria in different
environmental media as sources of human
exposure to antibiotic resistance genes.
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